News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|January 1, 2002

Contemporary OB/GYN News Watch

News Briefs

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Pauline Maki, PhD, on why CBT for insomnia is underused in menopause care despite strong evidence

ByPauline Maki, PhD

June 29th 2026

5 women's health FDA headlines you missed in Q2 2026| Image credit: Contemporary OB/GYN

5 women's health FDA headlines you missed in Q2 2026

ByJoshua Fitch, Senior Editor

June 29th 2026

Latency antibiotics linked to prolonged pregnancy duration and improved survival after previable PPROM | Image credit: Stock.Adobe.com

Latency antibiotics linked to prolonged pregnancy duration and improved survival after previable PPROM

ByJoshua Fitch, Senior Editor

June 29th 2026

Previewing women's health regulatory updates and conferences in the 2nd half of 2026 | Image credit: Stock.adobe.com

Previewing women's health regulatory updates and conferences in the 2nd half of 2026

ByContemporary OB/GYN Staff

June 26th 2026

Blur image of medical clinic | © whyframeshot - stock.adobe.com

Cesarean scar ectopic pregnancy: Management updates and challenges in a post-Roe era

ByPatrice Trowbridge, MD,Nicole Economou, MD, MPH

June 26th 2026

Latest CME

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

Previewing women's health regulatory updates and conferences in the 2nd half of 2026

Cesarean scar ectopic pregnancy: Management updates and challenges in a post-Roe era

Latency antibiotics linked to prolonged pregnancy duration and improved survival after previable PPROM

FAQ: What you need to know about ACOG's new maternal immunization schedule

5 women's health FDA headlines you missed in Q2 2026